New drug combo shows promise in fighting stubborn hepatitis b
Disease control
Completed
This study tested whether adding an experimental drug called AB-729 to standard hepatitis B medications could better control the virus. Researchers enrolled 43 people with chronic hepatitis B who were already taking antiviral drugs. They wanted to see if this combination was safe…
Phase: PHASE2 • Sponsor: Arbutus Biopharma Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC